Home / Stocks / QGEN

Qiagen N.V. (QGEN, Lab tools & research services) Stock Valuation & Fair Value

Weak on forward returns

Qiagen N.V. (QGEN, Lab tools & research services) trades at a current P/E of 20.8, about 10% below its historical normal valuation, with a forward growth estimate of 8.1% and a PEG of 2.57. Analysts' one-year estimates have been hit 73% of the time. Priced at its historical normal P/E of 23.0 on the same blended earnings, the 2026-11-06 close of $50.33 corresponds to about $55.70 a share. This is a valuation reference, not a price target.

How to read these numbers: the PEG ratio and current P/E versus normal P/E.

DATA AS OF 2026-11-07
Current P/E
20.8
Normal P/E
23.0
PEG
2.57
Fwd growth
8.1%
Div yield
0.7%
RSI (14)
67.9
Neutral
Technical context
  • Price $50.33 at the Nov 6 close, 2.8% above the 20-day average ($48.94) and 9.8% above the 50-day ($45.83).
  • RSI (14) at 67.9.
  • 52-week range $32.34 to $55.16: the price is 8.8% below the high and 55.6% above the low.

The Street vs SeerForecast

Wall Street's mean price target for QGEN is $49.02 across 11 analysts, 2.6% below the current price. The average analyst rating is Hold. Our SeerForecast read of the same stock, formed without analyst targets: weak on forward returns. When the two disagree, start your digging there.

Valuation flags

Verdict history

tickerseer's rating moved from mixed on our tests (2026-07-31) to weak on forward returns (2026-11-02).

Current P/E and rating by weekCurrent P/E moved from 17.2 to 20.7 between 2026-07-31 and 2026-10-30, against a normal P/E of 23.0, with 3 rating changes over 14 recorded weeks.2026-07-31: P/E 17.2, Mixed on our tests, recalculated for the week of 2026-07-312026-07-31: P/E 17.2, Mixed on our tests, recorded live 2026-08-032026-08-07: P/E 17.2, Mixed on our tests, recalculated for the week of 2026-08-072026-08-07: P/E 17.6, Mixed on our tests, recorded live 2026-08-102026-08-14: P/E 17.6, Mixed on our tests, recalculated for the week of 2026-08-142026-08-14: P/E 17.8, Mixed on our tests, recorded live 2026-08-172026-08-21: P/E 17.8, Mixed on our tests, recalculated for the week of 2026-08-212026-08-21: P/E 18.3, Weak on forward returns, recorded live 2026-08-242026-08-27: P/E 18.3, Weak on forward returns, recalculated for the week of 2026-08-272026-08-28: P/E 18.3, Weak on forward returns, recalculated for the week of 2026-08-282026-08-28: P/E 18.3, Weak on forward returns, recalculated for the week of 2026-08-302026-08-28: P/E 17.9, Mixed on our tests, recorded live 2026-08-312026-09-04: P/E 17.9, Mixed on our tests, recalculated for the week of 2026-09-052026-09-04: P/E 18.0, Mixed on our tests, recorded live 2026-09-072026-09-11: P/E 18.0, Mixed on our tests, recalculated for the week of 2026-09-122026-09-11: P/E 17.6, Mixed on our tests, recorded live 2026-09-142026-09-18: P/E 17.6, Mixed on our tests, recalculated for the week of 2026-09-192026-09-18: P/E 17.9, Mixed on our tests, recorded live 2026-09-212026-09-25: P/E 18.3, Weak on forward returns, recalculated for the week of 2026-09-262026-09-25: P/E 18.3, Weak on forward returns, recorded live 2026-09-282026-10-02: P/E 18.5, Weak on forward returns, recalculated for the week of 2026-10-032026-10-02: P/E 18.5, Weak on forward returns, recorded live 2026-10-052026-10-09: P/E 18.8, Weak on forward returns, recalculated for the week of 2026-10-102026-10-09: P/E 18.8, Weak on forward returns, recorded live 2026-10-122026-10-16: P/E 19.1, Weak on forward returns, recalculated for the week of 2026-10-172026-10-16: P/E 19.1, Weak on forward returns, recorded live 2026-10-192026-10-23: P/E 20.8, Weak on forward returns, recalculated for the week of 2026-10-242026-10-23: P/E 20.8, Weak on forward returns, recorded live 2026-10-262026-10-30: P/E 20.7, Weak on forward returns, recalculated for the week of 2026-10-312026-10-30: P/E 20.7, Weak on forward returns, recorded live 2026-11-0218.020.022.0Jul 31Aug 23Sep 15Oct 7Oct 30Normal P/E 23.0
Mixed on our testsWeak on forward returns

Not every point was recorded live. Points marked recalculated are worked out from the metrics tickerseer archived that week.

Selected weeks: the first, the latest, every week the rating moved, and the cheapest and dearest.

WeekCurrent P/EPremium to normal P/ERating
2026-07-31P/E 17.2-25%Mixed on our tests (recalculated)
2026-08-03P/E 17.2-25%Mixed on our tests
2026-08-24P/E 18.3-20%Weak on forward returns
2026-08-31P/E 17.9-22%Mixed on our tests
2026-09-26P/E 18.3-20%Weak on forward returns (recalculated)
2026-10-24P/E 20.8-9%Weak on forward returns (recalculated)
2026-11-02P/E 20.7-10%Weak on forward returns ← now
Show all 30 readings
WeekCurrent P/EPremium to normal P/ERating
2026-07-31P/E 17.2-25%Mixed on our tests (recalculated)
2026-08-03P/E 17.2-25%Mixed on our tests
2026-08-07P/E 17.2-25%Mixed on our tests (recalculated)
2026-08-10P/E 17.6-24%Mixed on our tests
2026-08-14P/E 17.6-24%Mixed on our tests (recalculated)
2026-08-17P/E 17.8-22%Mixed on our tests
2026-08-21P/E 17.8-22%Mixed on our tests (recalculated)
2026-08-24P/E 18.3-20%Weak on forward returns
2026-08-27P/E 18.3-20%Weak on forward returns (recalculated)
2026-08-28P/E 18.3-20%Weak on forward returns (recalculated)
2026-08-30P/E 18.3-20%Weak on forward returns (recalculated)
2026-08-31P/E 17.9-22%Mixed on our tests
2026-09-05P/E 17.9-22%Mixed on our tests (recalculated)
2026-09-07P/E 18.0-22%Mixed on our tests
2026-09-12P/E 18.0-22%Mixed on our tests (recalculated)
2026-09-14P/E 17.6-23%Mixed on our tests
2026-09-19P/E 17.6-23%Mixed on our tests (recalculated)
2026-09-21P/E 17.9-22%Mixed on our tests
2026-09-26P/E 18.3-20%Weak on forward returns (recalculated)
2026-09-28P/E 18.3-20%Weak on forward returns
2026-10-03P/E 18.5-19%Weak on forward returns (recalculated)
2026-10-05P/E 18.5-19%Weak on forward returns
2026-10-10P/E 18.8-18%Weak on forward returns (recalculated)
2026-10-12P/E 18.8-18%Weak on forward returns
2026-10-17P/E 19.1-17%Weak on forward returns (recalculated)
2026-10-19P/E 19.1-17%Weak on forward returns
2026-10-24P/E 20.8-9%Weak on forward returns (recalculated)
2026-10-26P/E 20.8-9%Weak on forward returns
2026-10-31P/E 20.7-10%Weak on forward returns (recalculated)
2026-11-02P/E 20.7-10%Weak on forward returns ← now

Frequently asked questions

Is Qiagen N.V. stock overvalued?

At a current P/E of 20.8 versus its historical normal P/E of 23.0, Qiagen N.V. trades about 10% below its typical valuation, with a PEG of 2.57 on 8.1% forward growth. tickerseer currently rates it weak on forward returns.

What is Qiagen N.V.'s fair value and PEG?

Qiagen N.V. trades at a current P/E of 20.8 against a historical normal P/E of 23.0, a PEG of 2.57, and a forward growth estimate of 8.1%. Priced at its historical normal P/E of 23.0 on the same blended earnings, the 2026-11-06 close of $50.33 corresponds to about $55.70 a share. This is a valuation reference, not a price target.

Has tickerseer's rating of Qiagen N.V. changed?

tickerseer's rating moved from mixed on our tests (2026-07-31) to weak on forward returns (2026-11-02).

What is the analyst price target for Qiagen N.V.?

The mean Wall Street price target for Qiagen N.V. is $49.02 across 11 analysts, 2.6% below the current price. tickerseer's SeerForecast verdict is formed independently of analyst targets.

Industry: Lab tools & research services. Create a free account to see the full analysis: the SeerAI score, its five quality sub-scores, valuation history, and an AI research note where we have one. Options setups and metric history are part of the paid plans.

See the full analysis →🔔 Track QGEN free: valuation & earnings alerts

Get the free weekly earnings preview

One email each Monday with the week's named earnings setups, the reasoning, and what settled last week. Strikes and sizing stay in Premium.

It's free, and you can unsubscribe any time. We also send a short product update once a month. Educational content, not investment advice.